| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-005-0081-5 |
| P698 | PubMed publication ID | 16283418 |
| P50 | author | Jing-Long Huang | Q61807822 |
| P2093 | author name string | Iou-Jih Hung | |
| Liang-Shiou Ou | |||
| Tien-Lung Tsai | |||
| Shih-Jung Chiu | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis | Q34244145 | ||
| Treatment and monitoring of patients with lupus nephritis | Q37835826 | ||
| Growth and endocrine function in children receiving long-term steroid therapy for renal disease | Q37953503 | ||
| Side-effects of intravenous cyclophosphamide pulse therapy | Q41432436 | ||
| Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 | ||
| Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients | Q43637712 | ||
| Modern treatment of childhood SLE. | Q43752800 | ||
| Lipid profiles in patients with systemic lupus erythematosus | Q43893016 | ||
| Lupus nephritis: prognostic factors in children | Q44108564 | ||
| Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children | Q44407318 | ||
| An overview of the treatment of childhood SLE. | Q47625953 | ||
| Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 | ||
| Intermittent intravenous cyclophosphamide therapy for lupus nephritis. | Q54352606 | ||
| Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only | Q67925070 | ||
| Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
| Dyslipoproteinemia in pediatric systemic lupus erythematosus | Q70396550 | ||
| Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial | Q71553667 | ||
| Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus | Q73407589 | ||
| Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy | Q74128750 | ||
| Damage in systemic lupus erythematosus and its association with corticosteroids | Q74175875 | ||
| P433 | issue | 4 | |
| P921 | main subject | lupus nephritis | Q1621830 |
| P304 | page(s) | 515-519 | |
| P577 | publication date | 2005-11-10 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy | |
| P478 | volume | 25 |
Search more.